GLAUKOS CORP (GKOS) Fundamental Analysis & Valuation

NYSE:GKOS • US3773221029

Current stock price

103.94 USD
+0.76 (+0.74%)
Last:

This GKOS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. GKOS Profitability Analysis

1.1 Basic Checks

  • GKOS had negative earnings in the past year.
  • GKOS had a negative operating cash flow in the past year.
  • GKOS had negative earnings in each of the past 5 years.
  • In the past 5 years GKOS reported 4 times negative operating cash flow.
GKOS Yearly Net Income VS EBIT VS OCF VS FCFGKOS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M -150M

1.2 Ratios

  • GKOS's Return On Assets of -21.01% is in line compared to the rest of the industry. GKOS outperforms 48.94% of its industry peers.
  • GKOS has a Return On Equity (-28.60%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -21.01%
ROE -28.6%
ROIC N/A
ROA(3y)-16.78%
ROA(5y)-12.99%
ROE(3y)-25.62%
ROE(5y)-20.8%
ROIC(3y)N/A
ROIC(5y)N/A
GKOS Yearly ROA, ROE, ROICGKOS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20

1.3 Margins

  • GKOS has a better Gross Margin (77.97%) than 89.89% of its industry peers.
  • In the last couple of years the Gross Margin of GKOS has grown nicely.
  • The Profit Margin and Operating Margin are not available for GKOS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.03%
GM growth 5Y5.66%
GKOS Yearly Profit, Operating, Gross MarginsGKOS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. GKOS Health Analysis

2.1 Basic Checks

  • GKOS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for GKOS has been increased compared to 1 year ago.
  • The number of shares outstanding for GKOS has been increased compared to 5 years ago.
  • Compared to 1 year ago, GKOS has a worse debt to assets ratio.
GKOS Yearly Shares OutstandingGKOS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
GKOS Yearly Total Debt VS Total AssetsGKOS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • GKOS has an Altman-Z score of 14.44. This indicates that GKOS is financially healthy and has little risk of bankruptcy at the moment.
  • GKOS's Altman-Z score of 14.44 is amongst the best of the industry. GKOS outperforms 93.62% of its industry peers.
  • GKOS has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.10, GKOS is in the better half of the industry, outperforming 65.96% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 14.44
ROIC/WACCN/A
WACC10.62%
GKOS Yearly LT Debt VS Equity VS FCFGKOS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 4.69 indicates that GKOS has no problem at all paying its short term obligations.
  • The Current ratio of GKOS (4.69) is better than 71.81% of its industry peers.
  • GKOS has a Quick Ratio of 4.06. This indicates that GKOS is financially healthy and has no problem in meeting its short term obligations.
  • GKOS has a better Quick ratio (4.06) than 72.34% of its industry peers.
Industry RankSector Rank
Current Ratio 4.69
Quick Ratio 4.06
GKOS Yearly Current Assets VS Current LiabilitesGKOS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. GKOS Growth Analysis

3.1 Past

  • GKOS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 52.63%, which is quite impressive.
  • The Revenue has grown by 32.33% in the past year. This is a very strong growth!
  • Measured over the past years, GKOS shows a quite strong growth in Revenue. The Revenue has been growing by 17.66% on average per year.
EPS 1Y (TTM)52.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
Revenue 1Y (TTM)32.33%
Revenue growth 3Y21.5%
Revenue growth 5Y17.66%
Sales Q2Q%35.66%

3.2 Future

  • GKOS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 47.14% yearly.
  • The Revenue is expected to grow by 24.73% on average over the next years. This is a very strong growth
EPS Next Y36.78%
EPS Next 2Y57.52%
EPS Next 3Y54.97%
EPS Next 5Y47.14%
Revenue Next Year22.68%
Revenue Next 2Y25.04%
Revenue Next 3Y26.87%
Revenue Next 5Y24.73%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GKOS Yearly Revenue VS EstimatesGKOS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
GKOS Yearly EPS VS EstimatesGKOS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4

More info and screens

Find the best growth stocksShow best growing peers

1

4. GKOS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GKOS. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GKOS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GKOS Price Earnings VS Forward Price EarningsGKOS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GKOS Per share dataGKOS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as GKOS's earnings are expected to grow with 54.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y57.52%
EPS Next 3Y54.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GKOS Dividend Analysis

5.1 Amount

  • No dividends for GKOS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GKOS Fundamentals: All Metrics, Ratios and Statistics

GLAUKOS CORP

NYSE:GKOS (3/30/2026, 10:31:41 AM)

103.94

+0.76 (+0.74%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-17
Earnings (Next)04-28
Inst Owners100.27%
Inst Owner Change0.99%
Ins Owners3.43%
Ins Owner Change1.79%
Market Cap6.04B
Revenue(TTM)507.44M
Net Income(TTM)-187.69M
Analysts83.64
Price Target137.48 (32.27%)
Short Float %5.15%
Short Ratio3.58
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.39%
Min EPS beat(2)-39.91%
Max EPS beat(2)39.14%
EPS beat(4)3
Avg EPS beat(4)12.06%
Min EPS beat(4)-39.91%
Max EPS beat(4)39.14%
EPS beat(8)5
Avg EPS beat(8)8.75%
EPS beat(12)7
Avg EPS beat(12)5.88%
EPS beat(16)10
Avg EPS beat(16)1.95%
Revenue beat(2)2
Avg Revenue beat(2)4.86%
Min Revenue beat(2)2.88%
Max Revenue beat(2)6.84%
Revenue beat(4)4
Avg Revenue beat(4)4.27%
Min Revenue beat(4)2.01%
Max Revenue beat(4)6.84%
Revenue beat(8)8
Avg Revenue beat(8)4.29%
Revenue beat(12)12
Avg Revenue beat(12)4.22%
Revenue beat(16)16
Avg Revenue beat(16)4.37%
PT rev (1m)0%
PT rev (3m)8.95%
EPS NQ rev (1m)-9.02%
EPS NQ rev (3m)-47.99%
EPS NY rev (1m)-63.94%
EPS NY rev (3m)-86.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.37%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)0.24%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.9
P/FCF N/A
P/OCF N/A
P/B 9.2
P/tB 13.49
EV/EBITDA N/A
EPS(TTM)-0.9
EYN/A
EPS(NY)-0.57
Fwd EYN/A
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS8.74
BVpS11.3
TBVpS7.71
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -21.01%
ROE -28.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.97%
FCFM N/A
ROA(3y)-16.78%
ROA(5y)-12.99%
ROE(3y)-25.62%
ROE(5y)-20.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.03%
GM growth 5Y5.66%
F-Score3
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 57.32%
Cap/Sales 4.78%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.69
Quick Ratio 4.06
Altman-Z 14.44
F-Score3
WACC10.62%
ROIC/WACCN/A
Cap/Depr(3y)42.14%
Cap/Depr(5y)76.69%
Cap/Sales(3y)4.29%
Cap/Sales(5y)7.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
EPS Next Y36.78%
EPS Next 2Y57.52%
EPS Next 3Y54.97%
EPS Next 5Y47.14%
Revenue 1Y (TTM)32.33%
Revenue growth 3Y21.5%
Revenue growth 5Y17.66%
Sales Q2Q%35.66%
Revenue Next Year22.68%
Revenue Next 2Y25.04%
Revenue Next 3Y26.87%
Revenue Next 5Y24.73%
EBIT growth 1Y19.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year65.11%
EBIT Next 3Y72.31%
EBIT Next 5YN/A
FCF growth 1Y42.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y75.88%
OCF growth 3YN/A
OCF growth 5YN/A

GLAUKOS CORP / GKOS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for GLAUKOS CORP?

ChartMill assigns a fundamental rating of 4 / 10 to GKOS.


What is the valuation status for GKOS stock?

ChartMill assigns a valuation rating of 1 / 10 to GLAUKOS CORP (GKOS). This can be considered as Overvalued.


How profitable is GLAUKOS CORP (GKOS) stock?

GLAUKOS CORP (GKOS) has a profitability rating of 2 / 10.